Key result
Review examines recent evidence on oral hormonal contraceptive use and female CVD risk.
Why the study?
The debate on whether oral hormonal contraception increases the risk of cardiovascular disease in females remains ongoing with inconsistent and controversial viewpoints.
Does oral hormonal contraception increase the risk of cardiovascular diseases in females?
Does oral hormonal contraception increase the risk of cardiovascular diseases in females?
This review summarizes the available and often controversial evidence regarding the association between oral hormonal contraceptive use and cardiovascular disease risk in females.
Answers are grounded in this paper and cite their sources.
May inform individualized contraceptive counseling; leaves open causal confirmation from prospective trials.
Oral hormonal contraception (OHC) is a widely employed method in females for the prevention of unintended pregnancies, as well as for the treatment of menstrual disorders, endometriosis, and polycystic ovarian syndrome. However, it is believed that with OHCs use, some females may have higher risk of cardiovascular diseases, such as hypertension, diabetes, myocardial infarction, thrombosis, and heart failure. Although such risks are infrequently detected in healthy young females with the use of oral contraceptives, slightly elevated risks of cardiovascular diseases have been observed among reproductive-aged healthy females. However, prolonged use of OHC has also been claimed to have protective cardiac effects and may contribute to reduced risk of cardiovascular disease. In fact, the debate on whether OHC administration increases the risk of cardiovascular diseases has been ongoing with inconsistent and controversial viewpoints. Nevertheless, a great deal of work has been carried out to understand the relationship between OHC use and the occurrence of cardiovascular risk in females who use OHC for preventing the unwanted pregnancy or treatment of other disorders. Therefore, in this review we summarize the most recent available evidence regarding the association between the use of oral hormonal contraceptives and the risk for cardiovascular disease in females who are using OHC to prevent unintended pregnancy.
No takes yet. Share an insight, caveat, or question.
Bhullar et al. (2024) conducted a review in Cardiovascular disease risk. Oral hormonal contraceptives was evaluated on Cardiovascular disease risk. This review summarizes recent evidence regarding the association between oral hormonal contraceptive use and the risk of cardiovascular diseases in females.
Synapse has enriched 10 related papers. Consider them for comparative context: